Optimization of a dihydropyrrolopyrazole series of transforming growth factor-beta type I receptor kinase domain inhibitors: discovery of an orally bioavailable transforming growth factor-beta receptor type I inhibitor as antitumor agent (Q46722349)
Jump to navigation
Jump to search
scientific article published on 4 March 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Optimization of a dihydropyrrolopyrazole series of transforming growth factor-beta type I receptor kinase domain inhibitors: discovery of an orally bioavailable transforming growth factor-beta receptor type I inhibitor as antitumor agent |
scientific article published on 4 March 2008 |
Statements
1 reference
Optimization of a dihydropyrrolopyrazole series of transforming growth factor-beta type I receptor kinase domain inhibitors: discovery of an orally bioavailable transforming growth factor-beta receptor type I inhibitor as antitumor agent (English)
1 reference
Hong-Yu Li
1 reference
William T McMillen
1 reference
Charles R Heap
1 reference
Denis J McCann
1 reference
Lei Yan
1 reference
Robert M Campbell
1 reference
Sreenivasa R Mundla
1 reference
Chi-Hsin R King
1 reference
Elizabeth A Dierks
1 reference
Bryan D Anderson
1 reference
Karen S Britt
1 reference
Karen L Huss
1 reference
Matthew D Voss
1 reference
Yan Wang
1 reference
David K Clawson
1 reference
Jonathan M Yingling
1 reference
J Scott Sawyer
1 reference
4 March 2008
1 reference
1 reference
51
1 reference
7
1 reference
2302-2306
1 reference
Identifiers
1 reference
1 reference